|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Who Needs a CEO? Lycera Strikes Deal with Pharma Giant Merck
|
Thomas Lee |
03/03/11 |
Detroit
|
|
Lycera Plows Ahead With Drugs To Treat Autoimmune Disorders
|
Thomas Lee |
02/24/11 |
Detroit
|
|
Amylin Regroups From FDA Smackdown, CalciMedica Plans Trial of New Anti-Immune Drug, FDA Gives CareFusion Recall Highest Priority, & More San Diego Life Science News
|
Bruce V. Bigelow |
10/21/10 |
San Diego
|
|
Taligen Collects $10M For Focus on Rare Diseases
|
Ryan McBride |
08/23/10 |
Boston
|
|
San Diego Entrepreneurs Exchange Provides Networking, Support for Early-Stage Startups
|
Denise Gellene |
02/19/10 |
San Diego
|
|
DataSphere and Halosource Get Funded, Sage Signs Up Pfizer, Zymo Raises $90M, & More Seattle-Area Deals News
|
Gregory T. Huang |
01/12/10 |
Seattle
|
|
Amazon Closes Zappos Deal, RF Arrays Raises Cash, 16 Under the Radar Financings, & More Seattle-Area Deals News
|
Gregory T. Huang |
11/03/09 |
Seattle
|
|
Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney
|
Luke Timmerman |
10/14/09 |
Seattle
|
|
CalciMedica Finds a New Pathway to Fight Autoimmune Disorders
|
Bruce V. Bigelow |
01/09/09 |
San Diego
|
|
Spaltudaq Harnessing Mother Nature’s Wisdom to Make Better Drugs For Infections
|
Luke Timmerman |
08/28/08 |
Seattle
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
